Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00484510 · ClinicalTrials.gov registry record · Phase 2
High Dose Ascorbic Acid Treatment of CMT1A
A Phase 2 study, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT00484510 is a Phase 2 study that has completed, run by Wayne State University. The registered enrollment target is 110 participants.
The verdict
NCT00484510, a Phase 2 study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study will look at the impact of ascorbic acid (Vitamin C) on the progression of disease in people with CMT1A as compared to volunteers receiving a placebo. This study will assess whether is it futile to proceed with a larger, longer-term, placebo-controlled study.
Interventions
- DRUG placebo
- DRUG Ascorbic acid (Vitamin C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00484510
The ClinicalTrials.gov registry entry for NCT00484510 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00484510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00484510 about?
NCT00484510 is a clinical study titled "High Dose Ascorbic Acid Treatment of CMT1A". This study will look at the impact of ascorbic acid (Vitamin C) on the progression of disease in people with CMT1A as compared to volunteers receiving a placebo. This study will assess whether is it futile to proceed with a larger, longer-term, placebo-controlled study.
What is the current status of trial NCT00484510?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2007-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00484510?
The interventions under investigation include: placebo (DRUG), Ascorbic acid (Vitamin C) (DRUG).
Who is sponsoring clinical trial NCT00484510?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.